Cigna Group stock gets a higher Piper Sandler target 2026-10-02

Published on 10/05/2026 at 20:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Piper Sandler lifted its Cigna target to USD 370.00 on October 2, 2026. Q2 revenue reached USD 71.668 billion, while the October 5 price was USD 272.18.

Draufsicht-Arrangement mit Aktienzertifikat, Krankenversicherungspolice, Stethoskop und Medikamentenfläschchen — Cigna Group Flatlay mit Aktienzertifikat ISIN US1255231003, Stethoskop, Versicherungspolice und Medikamentenfläschchen auf weißem Untergrund, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) stock was trading at USD 272.18 on the NYSE on October 5, 2026 at 2:08 p.m. ET, up 0.61 percent. Piper Sandler raised its price target from USD 346.00 to USD 370.00 on October 2, 2026, keeping an Overweight rating on the shares.

Piper Sandler raises its target

According to Markets Insider on October 2, 2026, analyst Jessica Tassan lifted Piper Sandler's target to USD 370.00 from USD 346.00 and retained the Overweight rating. The report also cited Cigna's long-term adjusted EPS growth target of 10 percent to 14 percent through 2030.

The target change followed Cigna's September 30 Investor Day. A filing summary published by MetaTrader states that the company reaffirmed 2026 adjusted EPS guidance of at least USD 30.45 and set a medical care ratio range of 83.7 percent to 84.7 percent.

Q2 revenue reaches USD 71.668 billion

For the quarter ended June 30, 2026, Cigna reported total revenue of USD 71.668 billion and diluted GAAP EPS of USD 6.29, according to NadirAlpha. The same Q2 update reported adjusted income from operations of USD 2.1 billion and adjusted EPS of USD 7.78, up from USD 7.20 in Q2 2025.

The reported figures put the strategic targets in a measurable frame. Cigna's 2026 adjusted EPS floor of USD 30.45 is 3.9 times the Q2 adjusted EPS of USD 7.78, although the annual guidance and quarterly figure use different time horizons.

Consensus remains above the market price

MarketBeat reports a Moderate Buy consensus from 23 analysts, with 15 Buy ratings and 8 Hold ratings. The average twelve-month price target is USD 338.24, while the published range runs from USD 290.00 to USD 400.00.

The next scheduled checkpoint is Cigna's Q3 2026 report on October 29, 2026, before the market opens, with a conference call at 8:30 a.m. ET, according to MarketBeat.

Cigna stock trades below yearly high

Cigna stock's October 5 intraday range was USD 266.57 to USD 272.20, with volume at 637,054 shares. Its 52-week range is USD 239.51 to USD 312.18, and its market capitalization is USD 71.9 billion as of October 5, 2026.